HKPD · Cellyan Biotechnology Co., Ltd · Financials
Market Cap
$6.16M
Shares
49.32M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$13.43M
-33.9%
FY2026
Net Income
-$1.14M
-4098.6%
FY2026
Gross Margin
10.32%
-1.6pp
FY2026
Operating Margin
-17.77%
-6.5pp
FY2026
Diluted EPS
-$0.07
-2200%
FY2026
Operating Cash Flow
-$751.6K
-232%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $13.43M | $20.31M | $16.69M | $12.56M | |
| $12.05M | $17.9M | $13.13M | $9.82M | |
| $1.39M | $2.42M | $3.56M | $2.74M | |
| 10.32% | 11.89% | 21.32% | 21.81% | |
| $79K | $66.09K | $58.24K | $73.99K | |
| -$2.39M | -$2.28M | -$1.95M | -$1.79M | |
| -17.77% | -11.25% | -11.71% | -14.27% | |
| -$2.31M | -$2.22M | -$1.9M | -$1.72M | |
| $133.85K | $97.67K | $82.77K | $23.24K | |
| -$1.13M | $36.11K | $1.53M | $1.02M | |
| $7666 | $63.17K | $196.25K | $22.57K | |
| -$1.14M | -$27.06K | $1.33M | $998.2K | |
| -8.46% | -0.13% | 7.97% | 7.95% | |
| USD/shares | -$0.07 | -$0.00 | $0.18 | $0.15 |
| USD/shares | -$0.07 | -$0.00 | $0.18 | $0.15 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.